Navigation Links
Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011
Date:10/12/2011

CHADDS FORD, Pa., Oct. 12, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter 2011 financial results on October 27, 2011 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results.  

David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, Alan Levin, executive vice president and chief financial officer, and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 800-901-5241 (domestic) or 617-786-2963 (international) and enter passcode 11948354.  Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from October 27 at 12:00 p.m. ET until 12:00 p.m. ET on November 10 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 77092041.

A simultaneous webcast of the call may be accessed by visiting www.endo.com.  In addition, a replay of the webcast will be available until 12:00 p.m. ET on November 10.  The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
2. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
3. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
4. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
5. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
6. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
7. OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
8. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
9. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
10. Top 450 Biotechnology (Pharmaceuticals) Report (Global)
11. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/1/2014)... companies EBI, LLC, of New Jersey , and ... pay the United States $6.07 million to ... the companies, bone growth stimulators. The settlement this week ... Biomet, Yue Yu, pursuant to the qui tam provisions ... , LLP, a Philadelphia -based personal injury law ...
(Date:11/1/2014)... Wash. , Oct. 31, 2014 Talyst, ... at the 2014 American Society of Consultant Pharmacists (ASCP) ... The meeting and expo will bring together pharmacists and ... the latest technologies. In recent years, ... focus for LTC pharmacies. The InSite® System, Talyst,s LTC ...
(Date:11/1/2014)... and CHICAGO , Oct. 31, 2014 ... Durata Therapeutics, Inc. (NASDAQ: DRTX ) today ... granted early termination of the waiting period under the ... to Actavis, pending acquisition of Durata. Logo ... termination of the HSR waiting period satisfies one of ...
Breaking Medicine Technology:Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors 2Talyst Exhibits at ASCP Annual Meeting 2Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 2Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 3Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 4Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 5Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata 6
... 2011 As part of a nationwide effort to prevent ... supporting National Prescription Drug Take-Back Day, which is ... on Saturday, October 29. "Unused prescription medicines that ... are not handled properly," said Paul Kaplan, M.D., BCBSD Vice ...
... information from a recent proprietary study affirming that seeing is ... seeing was an overwhelming choice, selected by 10 times as ... "This research affirms how important seeing is to people and ... VisionSpring President. "With over 700 million people in the world ...
Cached Medicine Technology:Blue Cross Blue Shield of Delaware Supports the Drug Enforcement Administration's "National Prescription Drug Take-Back Day" 2VisionSpring Research Finds Seeing to be the Most Important of Five Senses 2
(Date:10/31/2014)... (PRWEB) October 31, 2014 Springboard ... for its small scale BioPro™ biodiesel processors, announced ... will further improve the performance and efficiency of ... GL95/MC12/BD380 trio will recover more than ... in with the glycerin by-product produced while making ...
(Date:10/31/2014)... October 31, 2014 The Memory Healer review ... by Alexander Lynch, whose father suffered from Alzheimer's disease. ... moment, caused by his father's disease. His father pointed a ... the crucial moment when the author of this method understood ... , The Memory Healer program is based on years ...
(Date:10/31/2014)... October 31, 2014 At the start ... families narrowly escaping carbon monoxide poisoning in their homes. ... weeks away, one family-owned, Missouri-based heating and cooling company ... making sure families start the home heating season with ... secure. , Beginning Nov. 1, 2014, E and ...
(Date:10/31/2014)... Surgery for low back pain caused by spinal stenosis ... live, a new report says. "Nearly 80 percent ... point in their lives, and about 30 million people ... problem," co-author Brook Martin, of the Dartmouth Institute of ... news release. In spinal stenosis, thickening of tissue ...
(Date:10/31/2014)... research suggests that insomnia is a major contributor to ... fatal injuries. The results underscore the importance of the ... Sleep Awareness Project. , Results show that the risk ... with the number of insomnia symptoms present. People with ... likely to die from a fatal injury than those ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2
... , ... ... , , , , ... ...
... A surge in volunteers following a major ... coordination, can actually make a situation worse instead of ... the devastating earthquake that rocked Haiti in January provides ... say the authors of a New England Journal ...
... ... in Direct Selling Industry With the Promotion of the First EcoAdvisor to Achieve EcoDirector ... ... one of its founding EcoAdvisors has reached the highest level of achievement, EcoDirector status. ...
... ... unrecognized set of targets and biomarkers to battle solid tumors. , ... (Vocus) February 24, 2010 -- Cancer researchers ... battle solid tumors. , , , , ,The findings center on discovery of signaling ...
... ... ... ... ...
... , ... ... ... ...
Cached Medicine News:Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 2Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 3Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 4Health News:Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field 5Health News:Health care volunteers and disasters: First, be prepared 2Health News:OnlyGreen Celebrates First EcoDirector 2Health News:New Cancer-Fighting Strategy Focuses On Signaling Molecules 2Health News:New Cancer-Fighting Strategy Focuses On Signaling Molecules 3Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 2Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 3Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 4Health News:U.S. Senate Urgently Needs to Extend 'Medicaid Match' in Economic Recovery Legislation 5Health News:Express Scripts Reports Strong Fourth Quarter Earnings 2Health News:Express Scripts Reports Strong Fourth Quarter Earnings 3Health News:Express Scripts Reports Strong Fourth Quarter Earnings 4Health News:Express Scripts Reports Strong Fourth Quarter Earnings 5Health News:Express Scripts Reports Strong Fourth Quarter Earnings 6Health News:Express Scripts Reports Strong Fourth Quarter Earnings 7Health News:Express Scripts Reports Strong Fourth Quarter Earnings 8Health News:Express Scripts Reports Strong Fourth Quarter Earnings 9Health News:Express Scripts Reports Strong Fourth Quarter Earnings 10Health News:Express Scripts Reports Strong Fourth Quarter Earnings 11Health News:Express Scripts Reports Strong Fourth Quarter Earnings 12Health News:Express Scripts Reports Strong Fourth Quarter Earnings 13Health News:Express Scripts Reports Strong Fourth Quarter Earnings 14Health News:Express Scripts Reports Strong Fourth Quarter Earnings 15Health News:Express Scripts Reports Strong Fourth Quarter Earnings 16Health News:Express Scripts Reports Strong Fourth Quarter Earnings 17Health News:Express Scripts Reports Strong Fourth Quarter Earnings 18Health News:Express Scripts Reports Strong Fourth Quarter Earnings 19Health News:Express Scripts Reports Strong Fourth Quarter Earnings 20Health News:Express Scripts Reports Strong Fourth Quarter Earnings 21Health News:Express Scripts Reports Strong Fourth Quarter Earnings 22
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
... Vitrasert implant is a device that ... Aids-related Cytomegalovirus (CMV) Retinitis. This approach ... when compared with conventional intravenous treatment. ... in a polymer-based system that slowly ...
Near PT test card/illus of the ocular adnexa 5 1/2" X 8"....
Medicine Products: